The company is an innovative pharmaceutical enterprise engaged in international competition, focusing on complex formulations, unique APIs, generics, and original new drugs to address unmet clinical needs globally. It has developed advanced drug technology platforms, including fermentation semi-synthesis, multi-chiral drug development, non-biological macromolecule production, drug-device combinations, and coupling drugs. The company specializes in therapeutic areas such as antifungal, antiviral, immunosuppression, oncology, cardiovascular, respiratory, and iron supplementation. Certified by GMP standards in China, the U.S., the EU, Japan, and South Korea, the company’s products are marketed worldwide, supported by a robust R&D foundation, global registration, and a comprehensive cGMP production system.